| 标题 |
88MO Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of Asian patients (pts) with HER2+ advanced/metastatic breast cancer (a/mBC): A DESTINY-Breast09 analysis |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Z. Jiang; Y.H. Park; M. Toi; S. Tolaney; Y. Chae; et al 出版日期:2025-12-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)